Altered DNA methylation, related to the fundamental role of epigenetic events in cancer (Jones and Baylin, 2002; Verma et al, 2004) now constitutes a growing field of clinical investigation in cancer (Das and Singal, 2004) and could possibly explain variable levels of GSTP1 expression in our patients. Here, GSTP1 is linked to cancer.